UA100849C2 - Normal;heading 1;heading 2;heading 3;METHOD FOR REPLICATING INFLUENZA VIRUS IN CULTURE - Google Patents

Normal;heading 1;heading 2;heading 3;METHOD FOR REPLICATING INFLUENZA VIRUS IN CULTURE

Info

Publication number
UA100849C2
UA100849C2 UAA200907428A UAA200907428A UA100849C2 UA 100849 C2 UA100849 C2 UA 100849C2 UA A200907428 A UAA200907428 A UA A200907428A UA A200907428 A UAA200907428 A UA A200907428A UA 100849 C2 UA100849 C2 UA 100849C2
Authority
UA
Ukraine
Prior art keywords
heading
culture
influenza virus
normal
replicating influenza
Prior art date
Application number
UAA200907428A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Терри Ли Васмон
Пенг ГАО
Бредли Аллен Эдди
Омар Юсиф АБДЕЛЬМАГИД
Original Assignee
Шеринг-Плау Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шеринг-Плау Лтд. filed Critical Шеринг-Плау Лтд.
Priority claimed from PCT/US2007/025636 external-priority patent/WO2008076371A2/en
Publication of UA100849C2 publication Critical patent/UA100849C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16051—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention is related to a method for selecting an influenza virus for growth on tissue culture cells to produce a tissue-culture adapted viral isolate. The invention also includes vaccines produced from the isolate.
UAA200907428A 2006-12-15 2007-12-14 Normal;heading 1;heading 2;heading 3;METHOD FOR REPLICATING INFLUENZA VIRUS IN CULTURE UA100849C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87528706P 2006-12-15 2006-12-15
PCT/US2007/025636 WO2008076371A2 (en) 2006-12-15 2007-12-14 Method for replicating influenza virus in culture

Publications (1)

Publication Number Publication Date
UA100849C2 true UA100849C2 (en) 2013-02-11

Family

ID=41484170

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200907428A UA100849C2 (en) 2006-12-15 2007-12-14 Normal;heading 1;heading 2;heading 3;METHOD FOR REPLICATING INFLUENZA VIRUS IN CULTURE

Country Status (4)

Country Link
CN (1) CN101610787B (en)
CA (1) CA2766173A1 (en)
UA (1) UA100849C2 (en)
ZA (1) ZA200904153B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011138229A1 (en) * 2010-05-03 2011-11-10 Glaxosmithkline Biologicals S.A. Novel method
BR112020005229A2 (en) * 2017-09-18 2020-09-24 Bayer Healthcare Llc virus inactivation methods using n-methylglucamide and its derivatives
AR113996A1 (en) * 2017-12-22 2020-07-08 Intervet Int Bv LIQUID VACCINES FOR LIVE WRAPPED VIRUSES
SG11202005528PA (en) * 2018-01-18 2020-07-29 Yisheng Biopharma Singapore Pte Ltd Method for adapting influenza viruses to vero cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
CN1729996A (en) * 2005-08-03 2006-02-08 中国人民解放军军事医学科学院军事兽医研究所 The preparation technology and the preparation of the important eqpidemic disease hyper-immune serum of Canis animals anti-canidae animal

Also Published As

Publication number Publication date
ZA200904153B (en) 2010-03-31
CN101610787A (en) 2009-12-23
CN101610787B (en) 2013-07-03
CA2766173A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
MX2009006469A (en) Method for replicating influenza virus in culture.
SG171577A1 (en) Methods for producing yeast-based vaccines
WO2006063053A3 (en) Methods of producing influenza vaccine compositions
EA200970271A1 (en) OBTAINING VACCINES AGAINST THE VIRUS OF THE INFLUENZA WITHOUT USING THE CHICKEN EMBRYOS
TN2011000628A1 (en) Production of polio virus at high titres for vaccine production
WO2008068631A8 (en) Vaccines including antigen from four strains of influenza virus
AU2016204319A1 (en) Methods and compositions for producing squalene using yeast
NO20054124L (en) Animal-free cell culture method
WO2007048089A3 (en) Multi-plasmid system for the production of influenza virus
MX2021006342A (en) Influenza virus mutants and uses therefor.
IL203869A (en) Method for the manufcture of a preparation comprising virus or viral antigens and various aspects related thereto, uses thereof and a split virus vaccine preparation obtained by the method
MX2009000520A (en) Methods for producing fuels and solvents.
EA201001045A1 (en) MODIFIED FLU VIRUS
NZ563125A (en) Lipid extract of mussels and method for preparation thereof
EA201071086A1 (en) ADVANCED METHOD FOR OBTAINING VACCINE ANTIGENS OF THE VIRUS VIRUS
CL2011000913A1 (en) Stable and completely liquid combined vaccine comprising diphtheria, tetanus, whole cell pertussis antigens, and poliomyelitis virus and optionally one or more antigens selected from haemophilus influenzae and hepatitis; and manufacturing process.
UA100849C2 (en) Normal;heading 1;heading 2;heading 3;METHOD FOR REPLICATING INFLUENZA VIRUS IN CULTURE
SG159525A1 (en) Vaccine
WO2007082734A3 (en) Influenza vaccine
GB2429711A (en) Heart and skeletal muscle inflammation (HSMI) virus
MX2009007790A (en) Improvement of cell growth.
HK1122997A1 (en) Vaccines comprising purified surface antigens prepared from influenza viruses grown in cell culture, adjuvanted with squalene
WO2008002152A3 (en) Process for culturing bacteria of the piscirickettsia genus
EP2017333A4 (en) Feline cell capable of being cultured without animal protein, and method for production of virus and method for production of vaccine using the feline cell
TW200833751A (en) Method for preparing polyester nanocomposites